LOAMU
TEVA icon

Lombard Odier Asset Management (USA)’s Teva Pharmaceuticals TEVA Stock Holding History

Lombard Odier Asset Management (USA)’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-28,443
Closed -$254K – 300
2019
Q3 		$196K Buy
+28,443
New +$218K 0.02% 240

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Lombard Odier Asset Management (USA)'s TEVA Position: Q4 2019 in Review

Lombard Odier Asset Management (USA) sold out of Teva Pharmaceuticals (TEVA) in Q4 2019, closing a stake of 28,443 shares — an estimated $254K sold.

Lombard Odier Asset Management (USA) first reported a position in TEVA in Q3 2019 and held it in 1 quarter. The position peaked at $196K in Q3 2019. 437 funds tracked by Wall St. Rank hold TEVA as of Q4 2019.

  • Lombard Odier Asset Management (USA) reported no remaining Teva Pharmaceuticals position as of Q4 2019 after selling out during the quarter.
  • Lombard Odier Asset Management (USA) sold 28,443 Teva Pharmaceuticals shares in Q4 2019, an estimated $254K.
  • Lombard Odier Asset Management (USA) first reported a position in Teva Pharmaceuticals in Q3 2019 and held it in 1 quarter.
  • Lombard Odier Asset Management (USA)'s Teva Pharmaceuticals position peaked at $196K in Q3 2019.
  • 437 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2019.

Based on Lombard Odier Asset Management (USA)'s 13F filing for Q4 2019, filed 14 Feb 2020.